This is a snippet of the transcript, sign up to read more.
Ingersoll Rand is a significant player. Absolutely, 100% global. Siemens as well. So, Atlas Copco, Siemens, and Ingersoll Rand, these three are definitely major players across the group. There were 19 plants situated globally. I'm not sure if you're familiar with it, but there's something called a plant criticality assessment. It's essentially a comprehensive risk assessment for a plant, based on a certain set of criteria such as age, maintenance history, and availability of spare parts for the machine. This assessment identifies the most critical pieces of equipment on the plant.
This is a snippet of the transcript, sign up to read more.
The compressors provide the plant with compressed air, which is required to operate the automation of all the equipment. This includes cylinders, pick and place units, rotary units, and the weigher. The compressed air isn't critical to the process, but it is critical to the equipment. Does that make sense?
This is a snippet of the transcript, sign up to read more.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2024 IP 1 Ltd. All rights reserved.